Apitope – Exit
Apitope is an established leader in discovery and development of antigen-specific immunotherapeutic peptides focused on autoimmune diseases.
| Sector: | Immunotherapeutics |
| Country: | United Kingdom / Belgium |
| Status: | Acive |
Vesalius Biocapital offers venture capital
to young European innovative life science companies